Discovering High-Affinity, Functional Anti-GPCR Antibodies
Read how Twist’s Synthetic Libraries were designed and used to identify GLP-1R antagonistic antibodies.
Partners work with Twist Biopharma to get to market faster by accessing our market-leading
phage display, mouse hybridoma, and single B-cell screening workflows.
Twist Biopharma is a trusted partner with a proven track record for developing superior antibody leads with drug like developability profiles
Read how Twist’s Synthetic Libraries were designed and used to identify GLP-1R antagonistic antibodies.
Learn how the Twist Antibody Optimization (TAO) service dramatically improved the affinity of an anti-PD1 antibody.
Read about rapid discovery of rare, specific antibodies against a cell surface target.
Read about enhanced epitopic coverage with a diverse range of affinity via DiversimAb and humanzied mice.
One of our sales experts will get back to you shortly
© 2025 Twist Bioscience. All rights reserved.